ATE135916T1 - Hirnaktivitätfördernde zubereitungen - Google Patents

Hirnaktivitätfördernde zubereitungen

Info

Publication number
ATE135916T1
ATE135916T1 AT92308053T AT92308053T ATE135916T1 AT E135916 T1 ATE135916 T1 AT E135916T1 AT 92308053 T AT92308053 T AT 92308053T AT 92308053 T AT92308053 T AT 92308053T AT E135916 T1 ATE135916 T1 AT E135916T1
Authority
AT
Austria
Prior art keywords
brain activity
activity promoting
cerebral performance
promoting preparations
brain
Prior art date
Application number
AT92308053T
Other languages
English (en)
Inventor
Joachim Bormann
Wolfgang Schatton
Ruediger Koch
Roman Goertelmeyer
Lothar Demisch
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Application granted granted Critical
Publication of ATE135916T1 publication Critical patent/ATE135916T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92308053T 1991-09-06 1992-09-04 Hirnaktivitätfördernde zubereitungen ATE135916T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/755,814 US5262162A (en) 1991-09-06 1991-09-06 Cerebral-activating extract

Publications (1)

Publication Number Publication Date
ATE135916T1 true ATE135916T1 (de) 1996-04-15

Family

ID=25040758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92308053T ATE135916T1 (de) 1991-09-06 1992-09-04 Hirnaktivitätfördernde zubereitungen

Country Status (11)

Country Link
US (1) US5262162A (de)
EP (1) EP0531155B1 (de)
JP (1) JPH05194247A (de)
KR (1) KR100256452B1 (de)
AT (1) ATE135916T1 (de)
CA (1) CA2077589A1 (de)
DE (1) DE69209414T2 (de)
DK (1) DK0531155T3 (de)
ES (1) ES2086666T3 (de)
GR (1) GR3020121T3 (de)
TW (1) TW217989B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59607480D1 (de) * 1995-05-17 2001-09-20 Peter Greither Verfahren zum Herstellen eines Brausepräparats und Brausepräparat
US5747006A (en) * 1997-05-14 1998-05-05 Amway Corporation Skin whitener composition containing acerola cherry fermentate
US5866585A (en) * 1997-05-22 1999-02-02 Synchroneuron, Llc Methods of treating tardive dyskinesia using NMDA receptor antagonists
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
DE59706616D1 (de) * 1997-10-27 2002-04-18 Gergely Gerhard Brausezubereitung mit Pflanzenextrakt
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
US6294583B1 (en) 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
CA2319318A1 (en) * 1998-01-27 1999-07-29 Thomas N. Thomas Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
US6413558B1 (en) 1999-07-19 2002-07-02 The Proctor & Gamble Co. Compositions, kits, and methods for providing and maintaining energy and metal alertness
DE102004041270A1 (de) 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
RU2571271C2 (ru) * 2010-08-27 2015-12-20 Финцельберг Гмбх Унд Ко. Кг Растительные экстракты из sideritis и их применение для усиления когнитивной способности
ES2721278T3 (es) * 2013-07-14 2019-07-30 Olle Svenssons Partiaffaer Ab Composiciones de alcaloides de la especie Ribes para tratar afecciones asociadas con la función mitocondrial o inhibición de pDE4, PDE5 e IKK-BETA
CN107250340B (zh) 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物
WO2019045575A1 (en) * 2017-08-28 2019-03-07 Vitality Wellness (Nz) Limited IMPROVEMENTS IN IGF-1 ANALYSIS, ADJUSTMENT AND DISEASE MANAGEMENT IN NON-NEUROLOGICAL AND / OR NEUROLOGICAL STATES
MX2021006062A (es) 2018-11-26 2021-07-06 Roar Holding Llc Metodos para mejorar la calidad de las bebidas.
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition
WO2023163606A1 (en) * 2022-02-28 2023-08-31 Arepa Ip Limited Bioactives and their uses
WO2025048651A1 (en) * 2023-08-25 2025-03-06 Arepa Ip Limited Bioactives and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR92301E (fr) * 1963-08-09 1968-10-25 Chibret Lab Perfectionnements apportés aux procédés pour l'obtention de glucosides notamment de glucosides d'anthocyanes
FR6760M (de) * 1967-05-30 1969-03-03
EP0092076B1 (de) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
GB2147911B (en) * 1983-10-14 1987-10-07 Nestle Sa A process for the preparation of fatty substances
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse
GB2183635B (en) * 1985-10-11 1990-01-24 Peter Jowett Glyceride ester of gamma-linolenic acid
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
FR2622453A1 (fr) * 1987-11-04 1989-05-05 Vaillant Defresne Laboratoire Composition sous forme de gel transparent contenant des grains ou des particules de plantes fraiches ou seches, son procede de preparation et utilisation en cosmetologie, en pharmacie et en hygiene

Also Published As

Publication number Publication date
US5262162A (en) 1993-11-16
JPH05194247A (ja) 1993-08-03
TW217989B (de) 1993-12-21
DE69209414T2 (de) 1996-12-05
DE69209414D1 (de) 1996-05-02
EP0531155B1 (de) 1996-03-27
KR100256452B1 (ko) 2000-05-15
ES2086666T3 (es) 1996-07-01
CA2077589A1 (en) 1993-03-07
EP0531155A1 (de) 1993-03-10
GR3020121T3 (en) 1996-08-31
DK0531155T3 (da) 1996-06-10

Similar Documents

Publication Publication Date Title
ATE135916T1 (de) Hirnaktivitätfördernde zubereitungen
Barsky Amplification, somatization, and the somatoform disorders.
Reitz et al. Adoption and the family system: Strategies for treatment.
Turner et al. Depression and disability: The stress process in a chronically strained population.
EP0715851A3 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
NO881657D0 (no) Medisinske preparater paa grunnlag av oelmaskekstrakt, fremgangsmaate for fremstilling -derav samt anvendelse av oelmaskekstrakt for fremstilling av kosmetiske preparater og et spesielt oelmaskekstrakt.
ATE100322T1 (de) Verwendung von uridin zur behandlung nervoeser stoerungen.
SV1998000138A (es) Uso de aminometil-cromanos sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal ref.lea 32408
Caplan Population-oriented psychiatry.
EP0267676A3 (de) Verwendung von 1,3-Di-n-butyl-7-(2-oxypropyl)xanthin zur Behandlung von zerebrovaskulären oder mit zerebraler Senilität assoziierten Störungen, von peripherer Gefässkrankheit und proliferativen Hautkrankheiten
ATE113478T1 (de) Verwendung antigener substanzen zur prophylaxe oder therapie von störungen und krankheiten im verdauungstrakt von tieren und menschen.
Sreenivasan et al. Right temporal lobe functions in psychiatric disorders.
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
Menon et al. Sertraline and liver toxicity in the elderly.
Dilley et al. Psychological complications of AIDS.
Dawe et al. Effects of a xanthine derivative, oxpentifylline, on certain psychological parameters of behaviour and performance
Cochrane Motor neurone disease
Ratanova EMOTIONAL ASSESSMENT OF AUDITORY-STIMULI OF DIFFERENT INTENSITY
Stein Workers' compensation proves the brain and body are connected: lessons for managed care
Manthorpe Holding hands and resolving grief.
Ulivelli et al. Acute carbamazepine toxicity after lamotrigine addition: description of 3 cases
Marrosu et al. Evaluation of cortical and hippocampal acetylcholine release during the sleep-wake cycle in freely moving cats: and EEG-dialysis study
Cantini et al. EEG Bereitschafts-like “giant” potentials, time-locked to myoclonus: a case report
Di Lazzaro et al. Reduction of motor cortex excitability in patients with cerebellar lesion
Ahlfors Magnetic source imaging of visually evoked and oscillatory electrical activity of the human brain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee